BioNTech SE Impairment Loss Recognised In Profit Or Loss Rightofuse Assets
BioNTech SE (BNTX) reported Impairment Loss Recognised In Profit Or Loss Rightofuse Assets of EUR 14.50 million for the 12-month period ending 2025-12-31, per its 20-F filed 2026-03-10.
Financial Statements › Expense Statement › Operating Expenses
ifrs-full:ImpairmentLossRecognisedInProfitOrLossRightofuseAssets · last filed 2026-03-10
| Period end | Impairment Loss Recognised In Profit Or Loss Rightofuse Assets 12 month |
|---|---|
| 2025-12-31 | 14.50M EUR 20-F · filed 2026-03-10 |